Construction and Expression of Ryanodine Receptor Mutants Relevant to Malignant Hyperthermia Patients in Japan

DOI 機関リポジトリ Web Site 被引用文献5件 参考文献29件
  • NAKANO Masahide
    Department of Pharmacology, Showa University School of Medicine Department of Surgery, Showa University Northern Yokohama Hospital
  • OYAMADA Hideto
    Department of Pharmacology, Showa University School of Medicine
  • YAMAZAWA Toshiko
    Department of Molecular Physiology, Jikei Medical University School of Medicine
  • MURAYAMA Takashi
    Department of Pharmacology, Juntendo University School of Medicine
  • NANBA Hokuto
    Department of Pharmacology, Showa University School of Medicine
  • IIJIMA Kentaro
    Department of Pharmacology, Showa University School of Medicine
  • OGUCHI Katsuji
    Department of Pharmacology, Showa University School of Medicine

この論文をさがす

抄録

Abstract: Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder triggered by exposure to commonly used volatile anesthetics. Pharmacological and genetic analyses implicated the type 1 of ryanodine receptor (RyR1) /Ca2+ release channel as the main candidate gene for causing MH. Genetic diagnosis of MH was proposed to replace conventional methods using biopsied muscle samples that are painful for patients and require skillful diagnosticians to interpret. However, more than 250 RyR1 gene variants have now been reported in MH-susceptible patients, although most have yet to be associated with functional abnormalities using exogenous constructs of these mutants expressed in living cells. To directly compare the pharmacological characteristics of some of the MH-related RyR1 mutants, we have established doxycycline -inducible cell lines expressing two of the unconfirmed rabbit RyR1 mutants, Q156K or R534H (corresponding to the Q155K or R533H mutations in human RyR1 reported in MH patients in Japan) and a confirmed mutant, R164C RyR1 (corresponding to the R163C mutation in human). The caffeine sensitivity of Q156K-expressing cells was remarkably enhanced compared to wild-type RyR1 and similarly to previously reported levels for R164C-expressing cells, while that of the R534H mutants was not different from wild-type cells. The resting cytosolic Ca2+ concentrations of cell lines expressing Q156K or R164C were much higher than those expressing R534H or wild-type RyR1. These results indicated that the RyR1 gene mutation causing the Q156K phenotype (Q155K in human) is potentially susceptible to MH, and that screening for this mutation could be useful for the noninvasive genetic diagnosis of MH in humans.

収録刊行物

被引用文献 (5)*注記

もっと見る

参考文献 (29)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ